Target intelligence / Profile preview

Higher brain regions involved in depression

Molecular classification
Other
01

Overview

The term 'Higher brain regions involved in depression' refers to a distributed network of neuroanatomical structures that mediate emotional and cognitive processes. Key components include the prefrontal cortex (PFC), which governs executive function and top-down emotional regulation, and the hippocampus, which is essential for memory and stress feedback. Other critical areas include the anterior cingulate cortex (ACC) and the amygdala, which process emotional salience and fear responses. In Major Depressive Disorder (MDD), these regions often exhibit structural atrophy, such as reduced dendritic branching and hippocampal volume, as well as functional dysregulation in synaptic connectivity. While these regions are the anatomical sites of depressive pathology, they do not constitute a single molecular target; instead, they contain numerous receptors and transporters (e.g., 5-HT receptors, NMDA receptors) that are the actual molecular targets for antidepressants and rapid-acting agents like ketamine.

Other names
Depression-related brain circuitsLimbic-cortical dysregulation white matterPrefrontal-limbic networkCortico-limbic system
02

Mechanism of action

Pharmacological agents modulate neurotransmitter systems (serotonin, norepinephrine, glutamate) within these regions to restore synaptic plasticity, enhance connectivity, and normalize circuit activity involved in mood regulation.

03

Biological functions

Emotional processingExecutive functionMood regulationCognitive controlStress responseMemory formation
04

Disease associations

Major Depressive Disorder (MDD)Bipolar DisorderAnxiety DisordersPost-Traumatic Stress Disorder (PTSD)
05

Safety considerations

Neurocognitive side effectsEmotional bluntingRisk of treatment-emergent maniaSuicidal ideation (particularly in adolescents)Dependence or withdrawal syndromes
06

Interacting drugs

Fluoxetine

6 more in the full profile.

07

Biomarkers

Reduced hippocampal volume (MRI)Reduced prefrontal cortex thicknessAltered functional connectivity (fMRI)Amygdala hyperactivityBrain-derived neurotrophic factor (BDNF) levels

Beyond the preview

Go deeper on Higher brain regions involved in depression.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Higher brain regions involved in depression.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call